Premium grade APIs designed for biological research, clinical diagnostics, and therapeutic synthesis.
In recent years, Rwanda has established itself as a pioneering hub for medical and biotechnological advancements in East Africa. Through strategic frameworks supervised by the Rwanda Food and Drugs Authority (Rwanda FDA), the country is actively building local capacities to reduce its reliance on imported pharmaceutical products. The Cholic Acid series products—comprising primary and secondary bile acids like Chenodeoxycholic Acid, Ursodeoxycholic Acid, and their conjugated salts—are foundational APIs. They play critical roles in synthesis chemistry, diagnostic reagents, and metabolic treatments. As Rwanda expands its pharmaceutical manufacturing in Kigali's Special Economic Zone, direct access to global standard manufacturers of bile acids is no longer a luxury but an absolute necessity for local manufacturing security.
“Building localized drug formulation capacity in East Africa requires reliable, certified API precursors. Our supply chain bridge connects state-of-the-art manufacturing pipelines directly to Kigali, assuring uninterrupted industrial growth.”
On a global scale, the demand for Cholic Acid derivatives is rising exponentially. These molecules serve as pivotal raw materials for synthesized drugs treating Primary Biliary Cholangitis (PBC), Nonalcoholic Steatohepatitis (NASH), and gallbladder disorders. In addition, secondary bile acids such as Deoxycholic Acid have witnessed soaring interest in clinical aesthetics (for localized fat reduction) and liposomal drug delivery technology. The global market value is supported by stringent international quality directives (USP, EP, JP standards), shifting manufacturers toward green-extraction technologies and highly optimized synthetic biology approaches to bypass ecological extraction constraints.
Unmatched purity profiles for complex chemical conversions and industrial animal nutrition.
Our state-of-the-art manufacturing plants in China leverage unmatched chemical engineering efficiencies, advanced crystallization techniques, and raw material access pathways. In contrast to smaller local production facilities, our facilities operate under fully integrated closed-loop automation, ensuring consistency across batch runs. For Rwandan buyers, this translates to stable wholesale pricing, guaranteed compliance with CE requirements, and scalability from pilot batches (5kg) to industrial-scale shipments (tens of metric tons).
Our logistics partners specialize in direct maritime routes ending in Dar es Salaam or Mombasa, backed by expedited overland routes straight to Kigali, ensuring reliable delivery timelines and optimized import custom processing.
| Product Derivative Name | Standard Purity (HPLC) | Primary Application Area | Certifications Available |
|---|---|---|---|
| Cholic Acid (CA) | ≥ 98.0% | Therapeutic Synthesis / Diagnostic Assays | CE, GMP, ISO9001 |
| Tauroursodeoxycholic Acid (TUDCA) | ≥ 99.0% | Cytoprotection / Liver Therapeutics | GMP, FDA Registered |
| Deoxycholic Acid (DCA) | ≥ 98.5% | Lipo-reduction Aesthetics / Cell Lysis | Halal, Kosher, CE |
| Ox Bile Powder | Total Bile Acids ≥ 45% | Animal Feed / Digestant Supplementation | GMP, Veterinary Health Cert |
Why regional distributors and multinational pharmaceutical buyers in Rwanda select Chengdu Chenlv Herb.
Collaborating with top research institutes to develop pure, ecological, and biochemically precise extraction pathways for bile derivatives.
Rigorous double-testing using HPLC, GC, and AAS. We strictly comply with ISO9001, ISO22000, HALAL, KOSHER, and FDA guidelines.
Fast turnaround times, custom logistics handling, and seamless shipping configurations directly targeting East African inland ports.
Expert insights on product specifications, regulatory compliance, and procurement timelines.
Explore our complete range of certified biochemical precursors and custom formulation options.
Chenlv Herb
